Axon shares rise as investors continue to digest strong Q1 results and recent large-agency contract momentum

Axon Enterprise, Inc. (AXON) is up 3.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to continued post-earnings momentum after Axon’s strong Q1 report and upbeat narrative around expanding software/AI adoption. Recent high-profile agency contract activity and fresh analyst price-target updates in early May may also be helping sentiment.

Details:

The company reported Q1 2026 revenue of $807 million, up 34% year over year, alongside adjusted EBITDA of $202 million (25.0% margin).

Within Software & Services, Axon highlighted that AI Era Plan-related product revenue (including offerings such as Draft One and Axon Assistant) rose more than 700% year over year.

A major U.S. city approved a 10-year contract valued at $153 million covering upgraded body-worn cameras and TASER devices, with AI features discussed as part of the rollout plan.

Several Wall Street analysts refreshed ratings and price targets in the days following the Q1 release, which can amplify buying interest as investors reassess forward expectations.

Sources:

Axon Investor Relations, CBS News, Stock Analysis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AXON Insider Trading Activity

$AXON insiders have traded $AXON stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.

Here’s a breakdown of recent trading of $AXON stock by insiders over the last 6 months:

PATRICK W SMITH (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 22 sales selling 30,000 shares for an estimated $16,711,709.
JOSHUA ISNER (PRESIDENT) has made 0 purchases and 10 sales selling 22,041 shares for an estimated $12,144,156.
BRITTANY BAGLEY (COO & CFO) has made 0 purchases and 7 sales selling 6,266 shares for an estimated $3,518,679.
JENNIFER H MAK (Chief Accounting Officer) has made 0 purchases and 4 sales selling 3,602 shares for an estimated $2,071,994.
ISAIAH FIELDS (Chief Legal Officer) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $1,070,016.
JEFFREY C KUNINS (CPO & CTO) has made 0 purchases and 5 sales selling 1,797 shares for an estimated $968,992.
CAITLIN ELIZABETH KALINOWSKI sold 930 shares for an estimated $497,879
JERI WILLIAMS has made 0 purchases and 3 sales selling 257 shares for an estimated $131,993.
ERIKA NARDINI sold 198 shares for an estimated $100,302

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$AXON Hedge Fund Activity

We have seen 544 institutional investors add shares of $AXON stock to their portfolio, and 666 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BAILLIE GIFFORD & CO added 1,516,099 shares (+1198.7%) to their portfolio in Q4 2025, for an estimated $861,038,105
WELLINGTON MANAGEMENT GROUP LLP added 878,378 shares (+57.0%) to their portfolio in Q1 2026, for an estimated $366,749,166
ALLIANCEBERNSTEIN L.P. removed 606,691 shares (-87.6%) from their portfolio in Q4 2025, for an estimated $344,558,019
WINSLOW CAPITAL MANAGEMENT, LLC removed 547,802 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $228,723,769
EDGEWOOD MANAGEMENT LLC added 537,895 shares (+36.1%) to their portfolio in Q1 2026, for an estimated $224,587,299
PRICE T ROWE ASSOCIATES INC /MD/ added 477,470 shares (+153.4%) to their portfolio in Q1 2026, for an estimated $199,358,049
UBS GROUP AG added 365,442 shares (+68.7%) to their portfolio in Q1 2026, for an estimated $152,582,998

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AXON Government Contracts

We have seen $73,351,328 of award payments to $AXON over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$AXON Analyst Ratings

Wall Street analysts have issued reports on $AXON in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Overweight" rating on 05/07/2026
Morgan Stanley issued a "Overweight" rating on 12/17/2025
RBC Capital issued a "Outperform" rating on 11/17/2025

To track analyst ratings and price targets for $AXON, check out Quiver Quantitative's $AXON forecast page.

$AXON Price Targets

Multiple analysts have issued price targets for $AXON recently. We have seen 11 analysts offer price targets for $AXON in the last 6 months, with a median target of $675.0.

Here are some recent targets:

Tim Long from Barclays set a target price of $523.0 on 05/08/2026
James Fish from Piper Sandler set a target price of $674.0 on 05/07/2026
Trevor Walsh from Citizens set a target price of $700.0 on 05/07/2026
Joseph Cardoso from JP Morgan set a target price of $755.0 on 05/07/2026
Andrew Spinola from UBS set a target price of $440.0 on 05/07/2026
Andrew Sherman from TD Cowen set a target price of $825.0 on 04/08/2026
Michael Ng from Goldman Sachs set a target price of $625.0 on 04/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.